Navigation Links
Cardinal Health, Prime Therapeutics Sign Primary Distribution Agreement
Date:7/31/2008

DUBLIN, Ohio, July 31 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced a three-year agreement with Prime Therapeutics, one of the nation's leading pharmacy benefit managers, to serve as its primary supply chain partner for branded and generic pharmaceuticals, effective August 1.

Prime Therapeutics managed more than $8.2 billion in prescription drug spend in 2007, and currently serves approximately 14.6 million members through Blue Cross and Blue Shield Plans, employer and union groups and third-party administrators.

"We look forward to delivering the pharmaceutical supply chain services that will help Prime Therapeutics continue to efficiently and effectively serve its patients' medication needs," said Mike Kaufmann, group president of Healthcare Supply Chain Services - Pharmaceutical for Cardinal Health. "This agreement is an excellent example of our commitment to building flexible, mutually beneficial partnerships with our customers that also enable us to grow our pharmaceutical distribution business."

Cardinal Health will also offer Prime Therapeutics additional supply chain optimization services to help improve its operational efficiency.

"This innovative new partnership will provide us with the benefits of buying through a drug wholesaler and the insights and expertise of direct generics buying," said Tim Dickman, Prime Therapeutics CEO. "Cardinal Health was selected as our primary distributor because they offer the experience, value-added services and flexibility that we need to continue to deliver quality, cost-efficient prescription drug benefits to our customers."

About Prime Therapeutics

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 10 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems, MedMined(TM) electronic infection surveillance service, VIASYS(R) respiratory care products and the CareFusion(TM) patient identification system. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at http://www.cardinalhealth.com.


'/>"/>
SOURCE Cardinal Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
2. New York Strengthens Emergency Preparedness with Cardinal Health Ventilators
3. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
4. Nanotechs health, environmental impacts worry scientists and the public
5. ETEX and LifeNet Health, Inc. Enter Agreement
6. IBF/LifeScience Alley MedTech Investing Conference Adds Ashley Boam, Acting Deputy Director for Science and Review Policy, Office of Device Evaluation, Center for Devices and Radiological Health, FDA
7. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
8. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
9. Primera Biosystems Raises $21 Million in Series B Private Round
10. Prime Therapeutics Receives VIPPS Accreditation
11. Berkley Life Sciences Introduces LS Prime: A Revolutionary New Primary Liability Policy for the Life Science Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... and LONDON , February 9, 2016 ... bio tech replace paper and protect IP ... electronic laboratory notebook (ELN) will be rolled out in ... research and development (R&D) and protect valuable IP. Users will ... follow a specific researcher or experiment as part of the ...
(Date:2/8/2016)... Feb. 8, 2016 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... ten finalists for clean technology companies in the TSX Venture ... 10 companies listed on the TSX Venture Exchange, in each ... clean technology & life sciences, diversified industries and ... given to return on investment, market cap growth, trading volume ...
(Date:2/8/2016)... N.C. , Feb. 8, 2016 Novan, Inc. today ... Chairman of the Board of Directors of Novan. In addition, ... North Carolina . --> ... Company also announced that it received a total of $32.8 million ... 2015 from its private investor network originating throughout the Research Triangle ...
(Date:2/8/2016)... ... February 08, 2016 , ... Bulk food product inspection systems ... various stages of the production process. Despite frequently inspecting loose product prior to ... packaging such as sacks of dry powders. , Mettler-Toledo Product Inspection's brand-new white ...
Breaking Biology Technology:
(Date:1/22/2016)... DUBLIN , January 22, 2016 ... has announced the addition of the  ... to their offering. --> ... of the  "Global Behavioral Biometric Market ... --> Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ...
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
(Date:1/13/2016)... , January 13, 2016 ... has published a new market report titled - Biometric Sensors ... and Forecast, 2015 - 2023. According to the report, the global ... and is anticipated to reach US$1,625.8 mn by 2023, ... 2023. In terms of volume, the biometric sensors market ...
Breaking Biology News(10 mins):